Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |